In our 40th anniversary year, we are proud to be joining the Dow Jones Industrial Average, an internationally recognized index for evaluating the performance of the U.S. stock market. #WeAreBiotech $AMGN
— Amgen (@Amgen) August 25, 2020
Eli Lilly @Lillypad and Amgen announce a manufacturing collaboration for #COVID19 antibody therapies. $AMGN
— Amgen (@Amgen) September 17, 2020
AI is used in speech recognition, electric cars, and now… for #osteoporosis. Crystal Bone, Amgen’s novel digital health algorithm under development, may one day advance a doctor’s ability to identify a patient’s risk of #osteoporosis bone fractures.
— Amgen (@Amgen) September 12, 2020
New data show that in the U.S., diagnosis and treatment of #osteoporosis varies from state to state in women who had an osteoporosis-related fracture. To learn more about the geographic variation of osteoporosis, visit the link below. #ASBMR2020
— Amgen (@Amgen) September 12, 2020
Supporting communities is a huge part of our mission, especially during #COVID19. Amgen South San Francisco recently donated 500 cloth masks to @ALASdreams, which will distribute them to their food pantry clients.
Check out other ways we've helped via the link below.
— Amgen (@Amgen) September 9, 2020
#ICYMI @AmgenOncology’s Christophe Bourdon connected with @PatrickDempsey to talk about our @DempseyCenter partnership, the upcoming Dempsey Challenge (going virtual this year!) and their personal connections to cancer through their moms.
— Amgen (@Amgen) September 5, 2020
We’re joining the @CDCFound, @MillionHeartsUS and health organizations in spotlighting the importance of heart health during #COVID19. Watch the @CDC-approved PSA below to learn more.
— Amgen (@Amgen) September 5, 2020
Learn more about this study at https://t.co/mKpkeM0Jb0. #COVID19 https://t.co/1WgpR7u5bC
— Amgen (@Amgen) September 2, 2020
Today, biotech pioneer @Amgen ($AMGN) joined the DJIA. Congrats on your addition as the 6th #NasdaqListed company on the 30-stock benchmark!
Learn more: https://t.co/E4fXHFjHk6 pic.twitter.com/hval73ehq1
— Nasdaq (@Nasdaq) August 31, 2020
During #COVID19, maintaining your heart health is more important than ever. That’s why we’ve joined @MillionHeartsUS on this important @CDC-approved PSA. Focus on your health, take your heart medication & don’t be afraid to keep your regular appointments.
Watch to learn more.
— Amgen (@Amgen) August 15, 2020
From working as nurses in the ICU to caring for the elderly to helping administer #COVID19 testing, Amgen's employees stepped up to help out over the last few months.
Click the link below to learn how each of them made a difference. #wearebiotech
— Amgen (@Amgen) August 29, 2020
Question: How can healthcare be better, faster, easier and more affordable?
Answer: Technology!
Amgen’s Patrick Dey offers his point of view on the rapidly emerging role of healthcare technology. Link to Patrick’s @Wired article below. #wearebiotech
— Amgen (@Amgen) August 15, 2020
'Seed and soil.’ @drsidmukherjee recently spoke at a virtual lecture hosted by Amgen about the term coined by Stephen Paget that continues to inform Mukherjee's thinking about cancer research.
Click below to hear more from the Pulitzer Prize winning author.
— Amgen (@Amgen) August 14, 2020
.@amgenfoundation partner @salkhanacademy shares his point of view on how to make virtual learning work during the time of #COVID19. Read his opinion piece in the link below. https://t.co/nmkXy2DJIU
— Amgen (@Amgen) August 13, 2020
Getting ready to return to college or go to college for the first time? Take 90 seconds to read some great career and life advice from our CEO Bob Bradway. Link below.
— Amgen (@Amgen) August 13, 2020
It’s “all hands on deck” in the fight against #COVID19. Click the link below to learn about the I-SPY COVID Trial and how it might be helpful in COVID-19 patients who need respiratory support.
— Amgen (@Amgen) August 10, 2020
We are proud to be a member of the COVID R&D Alliance and to work with our peers to identify potential treatment options that may address the urgent needs of patients living with #COVID19. Click below to learn about the work underway. #wearebiotech
— Amgen (@Amgen) August 4, 2020
While vaccines offer promise in the future, patients with #COVID19 need treatment options urgently. Amgen, @AbbVie and @TakedaPharma, members of the COVID R&D Alliance, are participating in the I-SPY COVID trial to investigate potential therapy candidates for COVID-19.
— Amgen (@Amgen) August 3, 2020
#BlackChemistsWeek pic.twitter.com/lF8v9yxDu8
— MC HAMMER (@MCHammer) August 6, 2020
People with serious heart conditions are at a higher risk for severe illness from #COVID19. Don’t neglect your heart health. Take your heart medication. Keep your regular appointments, and call your medical team with concerns.
Watch this @CDC-approved PSA to learn more.
— Amgen (@Amgen) September 19, 2020
For people with lung cancer, expanded biomarker testing is key to advancing science. Read more about @Amgenoncology's work with emerging biomarkers KRAS G12C and DLL3. Link below.#ESMO20$AMGN
— Amgen (@Amgen) September 18, 2020
Part of recovering from a heart attack is managing your cholesterol levels and making changes to your lifestyle.
Make sure you and your family #DontMissABeat. pic.twitter.com/W3OwGMZZC5
— Amgen (@Amgen) September 18, 2020
It’s not too late to sign up for the Dempsey Challenge. Just pick your activity, your distance and fundraising goal. Join us and the @Dempsey_Center for this virtual event to support patients.
Remember, no one beats cancer alone. It takes a team!#Reimaginethechallenge
— Amgen (@Amgen) September 18, 2020
We're proud to share that the @MELLODDY_IMI project has successfully trained a unique predictive model across 10 #biopharma and pharma companies.
Its potential: advancing #drugdiscovery by addressing data-sharing challenges within pharma research. https://t.co/WZQLafz4kn
— Amgen (@Amgen) September 17, 2020
Amgen to showcase data from #oncology pipeline in solid tumors during the European Society for Medical Oncology’s Virtual Congress, kicking off this weekend. #ESMO2020$AMGN
— Amgen (@Amgen) September 16, 2020
Three quick facts about Nancy:
She's a lawyer.
She's originally from Argentina.
She aspires to build the next generation of compliance officers.Read the Q&A with her via the link below. #wearebiotech
— Amgen (@Amgen) September 16, 2020
Thanks to Edda for her work in insuring everyone at Amgen feels embraced and respected. We’re highlighting her leadership to kick off #HispanicHeritageMonth today.
Learn more about our commitment and actions to DI&B via the link below.#wearebiotech
— Amgen (@Amgen) September 15, 2020
Amgen and @MBiolabs announce 2020 Amgen Golden Ticket winners: BigHat Biosciences and Trilo Therapeutics.
“Funding these companies and providing them the necessary lab space to move their science forward is so important,” said Amgen’s Flavius Martin. (thread)#wearebiotech
— Amgen (@Amgen) September 15, 2020
Amgen's Dr. David Reese talked to @ResearchAmerica about what inspired him to pursue a career in medicine and science. Hint: It was a book written by Charles Darwin that you may have heard of. Looks like David has added to his book collection since then. #RAForum
— Amgen (@Amgen) September 15, 2020
Amgen’s Susan Sweeney tackles everything – from personal stories to her work at Amgen to the five changes she would implement to improve our healthcare system – in a recent interview with @AuthorityMgzine. #wearebiotech
— Amgen (@Amgen) September 14, 2020
Congrats to David Baker on receiving this year’s Breakthrough Prize in Life Sciences award. Learn how Amgen is working with David and the @UWproteindesign team in the search for new medicines: https://t.co/sUCZMfFzao https://t.co/XN8JDjJW7x
— Amgen (@Amgen) September 14, 2020
Crystal Bone, Amgen’s novel digital health algorithm under development, may one day advance a doctor’s ability to identify a patient’s risk of #osteoporosis bone fractures. #digitalhealth #AI
— Amgen (@Amgen) September 13, 2020
Supporting communities is a huge part of our mission, especially during #COVID19. Amgen South San Francisco recently donated 500 cloth masks to @ALASdreams, which will distribute them to their food pantry clients.
Check out other ways we've helped via the link below.
— Amgen (@Amgen) September 9, 2020
#ICYMI @salkhanacademy & @AmgenFoundation's @EduardoCetlin recently connected to talk about supporting the next generation of #STEM leaders and innovators by building scientific literacy and sparking curiosity.
Watch their conversation via link below.
— Amgen (@Amgen) September 9, 2020
There have been some recent conversations in the news about #migraine, a debilitating and misunderstood disease. Hear more from Amanda, who experienced the stigma and shares hope for others.
— Amgen (@Amgen) September 8, 2020
Lowering your cholesterol is one of the most important ways to prevent another heart attack.
Amgen is proud to support AHA’s Check. Change. Control. Cholesterol initiative. Thank you @American_Heart for spreading this important message. https://t.co/uZNz7DallU
— Amgen (@Amgen) September 4, 2020
Congrats to @STATNews on this impressive milestone!
We’re happy Amgen has been able to contribute, including this one by @AmgenFoundation’s @EduardoCetlin: https://t.co/BlyV0NB95W and this recent one about #COVID19 co-authored by Amgen’s Dr. David Reese: https://t.co/KaBbB35szH https://t.co/UTJkgxvgpq
— Amgen (@Amgen) September 3, 2020
This year’s winners are making significant contributions in the fields of biology, chemical biology and chemistry. #wearebiotech#STEM
— Amgen (@Amgen) September 3, 2020
It’s #ChildhoodCancerAwarenessMonth and we’re sharing one of our top posts on social media from last year. Click the link below to learn the story behind this emotional moment.
In honor of #CCAM, we hope you will consider becoming a bone marrow donor.
— Amgen (@Amgen) September 2, 2020
In our latest video for the #ESCCongress, watch as Dr. Darryl Sleep, Chief Medical Officer, shares why continuity of care is so important for cardiovascular patients during #COVID19.$AMGN pic.twitter.com/WF9DHmzTWJ
— Amgen (@Amgen) August 31, 2020
"The COVID-19 pandemic has illustrated the necessity to continue to raise awareness on the need to diagnose and promptly treat cardiovascular disease, one of society’s most prevalent serious illnesses."
Read Amgen’s Dr. Isma Benattia article via link below.#ESCCongress
— Amgen (@Amgen) August 30, 2020
Watch Amgen Executive Medical Director Dr. Bart Molemans talk about how many patients aren’t achieving the recommended LDL-C targets, and why more intensive lipid-lowering is needed. #ESCCongress$AMGN pic.twitter.com/s8Mr9D2fMA
— Amgen (@Amgen) August 30, 2020
Together with @Servier and @Cytokinetics, we continue our commitment to improving awareness of #heartfailure with reduced ejection fraction during this year’s #ESCCongress.
— Amgen (@Amgen) August 29, 2020
New data from a Phase 3 trial brings us one step closer to another treatment option for children living with heterozygous familial hypercholesterolemia (HeFH).
Our team will be presenting this data virtually at #ESCCongress. $AMGN
— Amgen (@Amgen) August 29, 2020
On this day − in a year so many once again march for justice − take a moment to read and reflect on Dr. King’s historic speech 57 years ago. The current climate is a reminder that we all have work to do to insure that systemic racism is addressed. #MarchOnWashington
— Amgen (@Amgen) August 28, 2020
Today marks the 100th anniversary of the ratification of the 19th amendment, which gave women in the United States the right to vote. We’re inspired by the suffragettes, but recognize more work remained to ensure women of color also received this right.#WomensEqualityDay
— Amgen (@Amgen) August 26, 2020
Therapies for #multiplemyeloma have come a long way since the turn of the century. Learn how a chance meeting between two academics years ago laid the groundwork to launch an innovative medicine for these patients.
— Amgen (@Amgen) August 21, 2020
Following the tragic explosion in #Beirut, Lebanon earlier this month, two Amgen employees share their recollections of what had been a typical day. One was at the supermarket; the other home drinking a cup of coffee.
Click the link below to find out what happened next.
— Amgen (@Amgen) August 20, 2020
Today, we announce the @US_FDA approved a new combination with one of our treatments for #multiplemyeloma. Press release in the link below. $AMGN
— Amgen (@Amgen) August 20, 2020
Amgen is proud to support this CDC-approved PSA to help spread the word about the importance of managing heart disease during #COVID19. https://t.co/Z3ZYxThiI3
— Amgen (@Amgen) August 13, 2020
There have been some important discussions this week about managing #mentalhealth during #COVID19. Click the link below for advice that may help if you are struggling during this stressful time.
— Amgen (@Amgen) August 6, 2020
Supporting communities is a big part of our mission. We're proud that Amgen South San Francisco was once again listed in the @SFBusinessTimes Top 100 Corporate Philanthropy Awards. https://t.co/ODxa0ix5uC
— Amgen (@Amgen) July 31, 2020
#TBT: Thirty years ago this week, the Americans with Disabilities Act (ADA) was signed into U.S. law, a landmark piece of civil rights legislation that banned discrimination based on mental & physical disabilities.
Learn more via link below. #ADA30LeadOn
— Amgen (@Amgen) July 30, 2020
Leveraging @SomaLogic’s proteomic technology will provide new approaches to help advance Amgen’s drug discovery and development efforts. $AMGN https://t.co/5sUMt6pakq
— Amgen (@Amgen) July 30, 2020
By harnessing @SomaLogic’s comprehensive proteomics
technology, Amgen can gain a deeper understanding of human health and discovery of drug development targets.Read more in the link below. $AMGN
— Amgen (@Amgen) July 30, 2020
Read more from @Amgen’s Chad Pettit in @OnBiosimilars. Article link below https://t.co/VEv1yH2Jd6
— Amgen (@Amgen) July 28, 2020
Amgen reports Q2 earnings. Join our senior leadership team for a call at 2pm PT/5pm ET to discuss business developments, including #COVID19 updates. Details in the link below. $AMGN
Safe Harbor: https://t.co/hxhdRHOpTa
— Amgen (@Amgen) July 28, 2020
Our industry is making progress towards advancing science literacy for all. @AmgenFoundation President, Eduardo Cetlin, discusses increasing STEM opportunities and advancing equity in STEM education during #COVID19. Read his guest blog at https://t.co/4XGRozj1fz
— PhRMA (@PhRMA) August 24, 2020
It may be necessary for those with higher risk factors to monitor their #cholesterol more often and take medication to manage cholesterol levels. @Amgen sponsors the American Heart Association’s #CheckChangeControl Cholesterol initiative. https://t.co/IJhXL3KSC1 pic.twitter.com/z5Exxxhe8Z
— American Heart News (@HeartNews) September 10, 2020
Congratulations to #NasdaqListed @Amgen who joins the Dow Jones Industrial Average (DJIA) on August 31, 2020. 👏👏👏 pic.twitter.com/9wz2kci56R
— Nasdaq (@Nasdaq) August 25, 2020
Learn about our oncology pipeline during the virtual #ESMO20. Get up close and personal with 10 of our investigational anticancer modalities in our new immersive #360PipelinePath video: https://t.co/8qxYpPZu2e
— Amgen Oncology (@AmgenOncology) September 18, 2020
If you have cancer, you are at higher risk of serious problems from some vaccine-preventable diseases, like the flu. Talk with your doctor to make sure you’re getting the right vaccinations at the right time. #NationalImmunizationAwarenessMonth pic.twitter.com/sibgL7DYHg
— Amgen Oncology (@AmgenOncology) August 7, 2020
Today is #WorldLungCancerDay and Christophe Bourdon, along with the @Amgen team reaffirms our commitment to those affected by the disease. For more information on our research in lung cancer visit https://t.co/nS2DiHLOzH. #WLCD pic.twitter.com/TTUKAbHNMN
— Amgen Oncology (@AmgenOncology) August 1, 2020
.@Amgen is dedicated to developing biologics, including biosimilars, across six therapeutic areas. Discover more about our commitment.
— Amgen Biosimilars (@AmgenBiosim) August 28, 2020
In a recent Q&A with @PharmaBoardroom, @Amgen’s Alper Ureten shares the strategy behind Amgen’s success with #biosimilars and emphasizes the need for competition in order to foster a robust marketplace with biosimilars. Read it here.
— Amgen Biosimilars (@AmgenBiosim) August 14, 2020
Competition supported by biosimilars has the potential to help alleviate some of the COVID-19-driven financial pressure for governments, hospitals, and patients, while delivering the clinical benefits of originator biologics. Read more from @Amgen’s Chad Pettit in @OnBiosimilars.
— Amgen Biosimilars (@AmgenBiosim) July 31, 2020
"Because free resources should be awesome resources." Through the vision of @RobertLue4edu and the support of @AmgenFoundation, LabXchange is and will stay free for learners and educators. And not just free: top quality. #ScienceMadePossible.#SciEd #EdTech pic.twitter.com/dmrI7Eo3JR
— LabXchange (@LabXchange) September 1, 2020
I had the opportunity to speak with the Association of Corporate Citizenship Professionals (@accprof) about @khanacademy, equity, and the @AmgenFoundation. #stem #equity #philanthropy https://t.co/KU9gghI1hb pic.twitter.com/3ReHIk6jL3
— Scott Heimlich (@ScottHeimlich) August 10, 2020
.@AmgenFoundation has awarded @khanacademy an additional $3 million to support educational equity during the pandemic. @salkhanacademy and @EduardoCetlin discuss the new grant. #CheddarLive pic.twitter.com/cXp1w8mEzn
— Cheddar🧀 (@cheddar) July 23, 2020
To bring quality science #education to all, we must reimagine science learning. This summer, our @ASP_GPO #SummerScienceSeries did just that with a virtual program focused on inspiring a wide range of undergraduate scientists. #ScienceMadePossible https://t.co/jK62mfxyGb pic.twitter.com/JmHU4bskzO
— Amgen Foundation (@AmgenFoundation) August 31, 2020
Take a moment to read the @USATODAY interview with Amgen Foundation partner @salkhanacademy in which he discusses how Khan Academy has seen a big uptick in use during #COVID19 and the organization’s plans to support virtual learning this fall. https://t.co/a9ZI4fydJc
— Amgen Foundation (@AmgenFoundation) July 30, 2020
We couldn't ask for a better partner. #ScienceMadePossible https://t.co/8gPA1HO7GV
— Amgen Foundation (@AmgenFoundation) July 23, 2020